Reducing optical interference in a fluidic device

Patent metadata

Field	Value
Publication number	US-11215610-B2
Application number	US-201815951720-A
Country	US
Kind code	B2
Filing date	Apr 12, 2018
Priority date	Oct 13, 2006
Publication date	Jan 4, 2022
Grant date	Jan 4, 2022

Abstract

This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications. In particular, the medical device reduces interference with an optical signal which is indicative of the presence of an analyte in a bodily sample.

First claim

The invention claimed is:

1. A system for detecting an analyte in a sample of bodily fluid, the system comprising:
a fluidic device having an identifier and a housing for running an assay to detect the analyte in the sample of bodily fluid, the fluidic device further comprising: at least one sample collection unit, an assay assembly, and a waste assembly, wherein the assay assembly comprises at least one reagent for generating a fluorescent signal indicative of the presence of the analyte in the sample of bodily fluid;
a reader assembly comprising an identification detector, a communication assembly, a controller, and a detection assembly, wherein the fluidic device is configured to be inserted into the reader assembly, and
wherein the identification detector is configured to:
detect the identifier of the fluidic device; and
transmit the identifier to the communication assembly,

wherein the communication assembly is configured to:
receive, from an external device, a protocol to execute on the fluidic device selected in response to detection of the identifier, wherein the protocol comprises instructions to the controller to run the assay;

wherein the detection assembly is configured to detect the analyte in the sample of bodily fluid by detecting the fluorescent signal based on the instructions in the protocol received from the external device, and
wherein the waste assembly comprises a quenching site and a quenching agent that inhibits an enzymatic reaction between the at least one reagent and a second reagent, thereby reducing interference with the fluorescent signal.

2. The system of claim 1 , wherein the communication assembly is further configured to:
receive the protocol from the external device in response to transmitting the identifier to the external device.

3. The system of claim 1 , wherein the communication assembly is further configured to:
transmit the fluorescent signal to the external device.

4. The system of claim 1 , wherein the detection assembly comprises one of a digital camera, a charge coupled device (CCD), a photomultiplier, or a phototube.

5. The system of claim 1 , wherein the assay assembly further comprises a reagent chamber, a reaction site, and a fluidic channel that connects the reagent chamber with the reaction site.

6. The system of claim 1 , wherein the quenching site further comprises an absorbent material saturated with the quenching agent.

7. A system for detecting an analyte in a sample of bodily fluid, the system comprising:
a fluidic device having a housing for running a immunoassay to detect the analyte in the sample of bodily fluid within the housing, the fluidic device comprising:
at least one sample collection unit;
an assay assembly in fluidic communication with the at least one sample collection unit, wherein the assay assembly comprises at least one reagent for generating a fluorescent signal indicative of the presence of the analyte in the sample of bodily fluid; and
a waste chamber, and

a reader assembly comprising an identification detector, a communication assembly, a controller, and a detection assembly, wherein the fluidic device is configured to be inserted into the reader assembly,
wherein the identification detector is configured to:
detect an identifier of the fluidic device; and
transmit the identifier to the communication assembly,

wherein the communication assembly is configured to:
receive, from an external device, a protocol to execute on the fluidic device selected in response to detection of the identifier, wherein the protocol comprises instructions to the controller to run the immunoassay;

wherein the detection assembly is configured to detect the analyte in the sample of bodily fluid by detecting the fluorescent signal based on the instructions in the protocol received from the external device; and
wherein the waste chamber comprises a quenching site and a quenching agent that inhibits an enzymatic reaction between the at least one reagent and a second reagent, thereby reducing interference of the fluorescent signal.

8. The system of claim 7 , wherein the communication assembly is further configured to:
receive the protocol from the external device in response to transmitting the identifier to the external device.

9. The system of claim 7 , wherein the detection assembly comprises one or more digital cameras, charge coupled devices (CCDs), photomultipliers, or phototubes.

10. The system of claim 7 , wherein the assay assembly further comprises at least one reagent chamber, at least one reaction site, and at least one fluidic channel that connects the at least one reagent chamber with the at least one reaction site.

11. The system of claim 7 , wherein the detection assembly is further configured to:
detect a concentration of the analyte in the sample of bodily fluid based on the fluorescent signal.

Assignees

• Labrador Diagnostics Llc

Inventors

• Gibbons Ian
• O'Connell Michael

Classifications

• B01L3/5027 Primary

  by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip · CPC title

• G01N33/536

  with immune complex formed in liquid phase · CPC title

• Y10T156/10

  Methods of surface bonding and/or assembly therefor · CPC title

• B01L2300/0816

  Cards, e.g. flat sample carriers usually with flow in two horizontal directions · CPC title

• G01N33/5304 Primary

  Reaction vessels, e.g. agglutination plates (for solid-phase systems G01N33/543) · CPC title